Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

INFUSION ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.6% 1.6% 1.6% 1.6% 1.6% 1.6% 1.6% 1.6%   Bankruptcy risk   5.6% 11.3% 6.6% 10.8% 5.9% 6.8% 10.2% 10.0%   Credit score (0-100)   42 21 35 22 38 35 24 25   Credit rating   BBB BB BBB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   801 350 1,337 251 748 674 0.0 0.0   EBITDA   350 -136 723 -294 239 165 0.0 0.0   EBIT   350 -136 723 -294 239 165 0.0 0.0   Pre-tax profit (PTP)   346.5 -147.7 712.4 -307.2 231.2 162.0 0.0 0.0   Net earnings   270.2 -117.6 554.6 -263.7 248.1 52.7 0.0 0.0   Pre-tax profit without non-rec. items   347 -148 712 -307 231 162 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   919 801 1,356 1,035 1,224 1,216 1,098 1,098   Interest-bearing liabilities   2.7 0.6 0.0 34.7 77.9 121 0.0 0.0   Balance sheet total (assets)   1,294 1,043 1,674 1,204 1,419 1,429 1,098 1,098   Net Debt   -558 -871 -968 -1,031 -960 -990 -1,098 -1,098     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   801 350 1,337 251 748 674 0.0 0.0   Gross profit growth   -12.5% -56.4% 282.6% -81.3% 198.4% -9.9% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,294 1,043 1,674 1,204 1,419 1,429 1,098 1,098   Balance sheet change%   43.5% -19.4% 60.4% -28.1% 17.8% 0.7% -23.1% 0.0%   Added value   350.1 -135.8 722.8 -293.5 239.1 165.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 -1.0 1.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   43.7% -38.8% 54.0% -117.1% 32.0% 24.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   31.9% -11.6% 53.2% -20.4% 18.2% 11.7% 0.0% 0.0%   ROI %   44.6% -15.8% 67.0% -24.2% 20.2% 12.6% 0.0% 0.0%   ROE %   34.5% -13.7% 51.4% -22.1% 22.0% 4.3% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   71.0% 76.8% 81.0% 85.9% 86.3% 85.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -159.4% 641.7% -133.9% 351.4% -401.7% -598.9% 0.0% 0.0%   Gearing %   0.3% 0.1% 0.0% 3.4% 6.4% 10.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   223.5% 734.7% 3,332.2% 79.1% 14.1% 4.5% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   4.3 6.0 8.8 7.1 7.3 6.7 0.0 0.0   Current Ratio   4.3 6.0 8.8 7.1 7.3 6.7 0.0 0.0   Cash and cash equivalent   560.8 872.0 968.1 1,066.1 1,038.2 1,111.2 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   995.0 870.5 1,483.4 1,034.7 1,224.0 1,215.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   350 -136 723 -294 239 165 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   350 -136 723 -294 239 165 0 0   EBIT / employee   350 -136 723 -294 239 165 0 0   Net earnings / employee   270 -118 555 -264 248 53 0 0